StudyFinds on MSN
FDA Data Shows Stunning Lack Of Diversity In U.S. Drug Trials
Only 6% of trials for FDA-approved drugs match America's diversity. Analysis reveals how trial location and design choices ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced additional data from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752) providing an overview of the efficacy ...
In addition to our demographic research, you can also read more details on our U.S. and international survey research. One key aspect of Pew Research Center’s agenda is the exploration of key ...
News-Medical.Net on MSN
Financial barriers drive low participation in cancer clinical trials
A study by Case Western Reserve University and University Hospitals researchers has overturned long-held assumptions about why more cancer patients don't enroll in clinical trials that could ...
Clinicians, researchers, health equity advocates and oncology professionals are encouraged to read and share the full study, which contributes to the growing body of evidence identifying disparities ...
From exclusion in trials to misdiagnosis and unsafe dosing, startup TrialMe is tackling the systemic roots of women’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results